Investors.kadmon.com is a subdomain of kadmon.com, which was created on 2002-04-10,making it 22 years ago.
Description:The Investor Relations website contains information about Kadmon Holdings, Inc.'s business for stockholders, potential investors, and financial...
Discover investors.kadmon.com website stats, rating, details and status online.Use our online tools to find owner and admin contact info. Find out where is server located.Read and write reviews or vote to improve it ranking. Check alliedvsaxis duplicates with related css, domain relations, most used words, social networks references. Go to regular site
HomePage size: 58.408 KB |
Page Load Time: 0.241414 Seconds |
Website IP Address: 184.28.219.8 |
Maryland Real Estate Investors Association - Maryland Real Estate Investors Association dev.mdreia.com |
Western Midstream - Investors - Investors investors.westernmidstream.com |
OMNOVA Solutions - Investors - Investors omnova.investorroom.com |
Investors | M.D.C. Holdings, Inc. ir.richmondamerican.com |
All Aboard America Holdings | All Aboard Transportation | AAA Holdings jobs.allaboardtransit.com |
Investors | Marathon Oil Corporation - Investors ir.marathonoil.com |
MGM China Holdings Limited - MGM China Holdings Limited en.mgmchinaholdings.com |
Life @ World Travel Holdings - World Travel Holdings | World Travel Holdings careers-wth.icims.com |
Axalta Coating Systems - Investors - Investors Overview ir.axaltacs.com |
Lumentum Holdings Inc - Investors investor.oclaro.com |
Avaya Holdings Corp. - Investors investors.avaya.com |
Investors | Energizer Holdings, Inc. investors.energizerholdings.com |
Connected Investors | Connect With Real Estate Investors static1.connectedinvestors.com |
RAYMOND JAMES COMPLETES ACQUISITION OF TRISTATE CAPITAL HOLDINGS, INC. | TriState Capital Holdings investors.tristatecapitalbank.com |
Investors - Toromont Industries Ltd. - Investors investor.toromont.com |
united states securities and exchange commission https://investors.kadmon.com/static-files/ce2e72ff-a0e2-4ac7-9539-4070c106bd27 |
Accept-Ranges: bytes |
Content-Encoding: gzip |
Content-Language: en |
Content-Type: text/html; charset=UTF-8 |
device: desktop |
ETag: "1603649110" |
Expect-CT: max-age=0, report-uri="/report-expect-ct-violation" |
Feature-Policy: "accelerometer none;ambient-light-sensor none;autoplay self;camera none;encrypted-media none;fullscreen self;geolocation self;gyroscope none;magnetometer none;microphone none;midi none;payment none;picture-in-picture none;speaker self;sync-xhr self;usb none;vibrate none;vr none", From-Origin: same |
Last-Modified: Sun, 25 Oct 2020 18:05:10 GMT |
Link: http://investors.kadmon.com/; rel="shortlink", https://investors.kadmon.com/investor-relations/; rel="canonical", https://investors.kadmon.com/investor-relations; rel="alternate"; hreflang="en", https://investors.kadmon.com/investor-relations; rel="revision" |
Referrer-Policy: no-referrer-when-downgrade |
X-Age: 1349 |
X-Cache-Hits: 16 |
X-Content-Type-Options: nosniff |
X-Drupal-Dynamic-Cache: UNCACHEABLE |
X-Frame-Options: SAMEORIGIN |
X-Request-ID: v-9effd578-16ec-11eb-966a-bfeadaeef346 |
X-UA-Compatible: IE=edge |
X-XSS-Protection: 1; mode=block |
Content-Length: 12350 |
X-EdgeConnect-MidMile-RTT: 1, 51 |
X-EdgeConnect-Origin-MEX-Latency: 25, 25 |
Cache-Control: public, max-age=0, s-maxage=1800 |
Expires: Sun, 25 Oct 2020 18:27:39 GMT |
Date: Sun, 25 Oct 2020 18:27:39 GMT |
Connection: keep-alive |
Vary: Accept-Encoding |
Set-Cookie: DrupalVisitorMobile=0; path=/; Secure; HttpOnly |
Strict-Transport-Security: max-age=15768000 ; preload |
charset="utf-8"/ |
content="Kadmon Holdings, Inc." property="og:site_name"/ |
content="website" property="og:type"/ |
content="The Investor Relations website contains information about Kadmon Holdings, Inc.'s business for stockholders, potential investors, and financial analysts." name="description"/ |
content="https://investors.kadmon.com/investor-relations" property="og:url"/ |
content="Investors - Kadmon Holdings, Inc." property="og:title"/ |
content="no-referrer" name="referrer"/ |
content="The Investor Relations website contains information about Kadmon Holdings, Inc.'s business for stockholders, potential investors, and financial analysts." property="og:description"/ |
content="Drupal 8 (https://www.drupal.org)" name="Generator"/ |
content="width" name="MobileOptimized"/ |
content="true" name="HandheldFriendly"/ |
content="width=device-width, initial-scale=1.0" name="viewport"/ |
Ip Country: United States |
City Name: Cambridge |
Latitude: 42.3603 |
Longitude: -71.0818 |
Toggle Navigation Search:Our Company Leadership Board of Directors Kadmon Commitment Contact Clinical Pipeline About Belumosudil Belumosudil in cGVHD Belumosudil in Systemic Sclerosis About KD033 Clinical Trials Science Preclinical Pipeline Biologics Monoclonal Antibody Discovery Platform IL-18 Platform Small Molecules Structure-Based Drug Design Publications and Posters Products Investors Investors Home News & Events Press Releases Presentations and Events Additional Publications and Posters Stock Information Stock Quote & Chart Analyst Coverage Historic Price Lookup Financials & Filings Corporate Governance Documents & Charters Management Board of Directors Investor Resources Investor/Media FAQs Contact Us Email Alerts Careers Search: Contact Investors Investors Home Investors Home Investors Kadmon is a fully integrated biopharmaceutical company engaged in the discovery, development and commercialization of small molecules and biologics to address disease areas of significant unmet medical need. We are developing product candidates within autoimmune and fibrotic diseases, oncology and genetic diseases. We leverage our multi-disciplinary research and clinical development team members, who prior to joining Kadmon had brought more than 15 drugs to market, to identify and pursue a diverse portfolio of novel product candidates, through in-licensing products and employing our small molecule and biologics platforms. Stock Quote Price Change High Oct 25, 2020 2:05 PM EDT Data Provided by Refinitiv. Minimum 15 minutes delayed. Recent News View Events Learn More Corporate Presentation View Print Page Email Alerts Contact Us Investors Home News & Events Press Releases Presentations and Events Additional Publications and Posters Stock Information Stock Quote & Chart Analyst Coverage Historic Price Lookup Financials & Filings Corporate Governance Documents & Charters Management Board of Directors Investor Resources Investor/Media FAQs Contact Us Email Alerts Investor Inquiries Ellen Cavaleri 646.490.2989 investors@kadmon.com Media Inquiries 1.833.900.5366 media@kadmon.com Business Development 1.833.900.5366 bd@kadmon.com450 East 29th Street New York, New York 10016 55 Cambridge Parkway, Suite 300E Cambridge, Massachusetts 02142 119 Commonwealth Drive Warrendale, Pennsylvania 15086 Site Map Privacy Policy Terms of Use California Compliance © 2020 Kadmon Holdings, Inc. All Rights...
Domain Name: KADMON.COM Registry Domain ID: 85469035_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.corporatedomains.com Registrar URL: http://cscdbs.com Updated Date: 2024-04-06T05:14:04Z Creation Date: 2002-04-10T20:52:17Z Registry Expiry Date: 2025-04-10T20:52:17Z Registrar: CSC Corporate Domains, Inc. Registrar IANA ID: 299 Registrar Abuse Contact Email: domainabuse@cscglobal.com Registrar Abuse Contact Phone: 8887802723 Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Name Server: NS1.SANOFI-SYNTHELABO.COM Name Server: NS2.SANOFI-SYNTHELABO.COM Name Server: NS3.SANOFI-SYNTHELABO.COM Name Server: NS4.SANOFI-SYNTHELABO.COM DNSSEC: unsigned >>> Last update of whois database: 2024-05-17T20:59:02Z <<<